Ethnic‐specificity, evolution origin and deleteriousness of Asian BRCA variation revealed by over 7500 BRCA variants derived from Asian population
International Journal of Cancer · 15.03.2023 · 152 (6) · 1159-1173
DOI: 10.1002/ijc.34359 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer, online erschienen am 30.11.2022. Verfasst von Zixin Qin und 17 weiteren Autor:innen. Beteiligte Einrichtung: Ministry of Education Frontiers Science Center for Precision Oncology, Cancer Centre and Institute of Translational Medicine, Department of Public He…. Hauptthemen laut MEDLINE: Breast Neoplasms, Ovarian Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Pathogenic variation in BRCA1 and BRCA2 ( BRCA ) causes high risk of breast and ovarian cancer, and BRCA variation data are important markers for BRCA ‐related clinical cancer applications. However, comprehensive BRCA variation data are lacking from the Asian population despite its large population size, heterogenous genetic background and diversified living environment across the Asia continent. We performed a systematic study on BRCA variation in Asian population including extensive data mining, standardization, annotation and characterization. We identified 7587 BRCA variants from 685 592 Asian individuals in 40 Asia countries and regions, including 1762 clinically actionable pathogenic variants and 4915 functionally unknown variants ( https://genemutation.fhs.um.edu.mo/Asian-BRCA/ ). We observed the highly ethnic‐specific nature of Asian BRCA variants between Asian and non‐Asian populations and within Asian populations, highlighting that the current European descendant population‐based BRCA data is inadequate to reflect BRCA variation in the Asian population. We also provided archeological evidence for the evolutionary origin and arising time of Asian BRCA variation. We further provided structural‐based evidence for the deleterious variants enriched within the functionally unknown Asian BRCA variants. The data from our study provide a current view of BRCA variation in the Asian population and a rich resource to guide clinical applications of BRCA ‐related cancer for the Asian population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ministry of Education Frontiers Science Center for Precision Oncology, Cancer Centre and Institute of Translational Medicine, Department of Public Health and Medical Administration, Faculty of Health Sciences, Universit…
ORCID-Profile: San Ming Wang
Zitieren
APA
Qin, Z., Li, J., Tam, B., Sinha, S., Zhao, B., Bhaskaran, S. P., Huang, T., Wu, X., Chian, J. S., Guo, M., Kou, S. H., Lei, H., Zhang, L., Wang, X., Lagniton, P. N. P., Xiao, F., Jiang, X., & Wang, S. M. (2023). Ethnic‐specificity, evolution origin and deleteriousness of Asian BRCA variation revealed by over 7500 BRCA variants derived from Asian population. International Journal of Cancer, 152(6), 1159-1173. https://doi.org/10.1002/ijc.34359
Vancouver
Qin Z, Li J, Tam B, Sinha S, Zhao B, Bhaskaran SP, et al. Ethnic‐specificity, evolution origin and deleteriousness of Asian BRCA variation revealed by over 7500 BRCA variants derived from Asian population. International Journal of Cancer. 2023;152(6):1159-1173. doi:10.1002/ijc.34359
BibTeX
@article{Qin2023,
author = {Qin, Zixin and Li, Jiaheng and Tam, Benjamin and Sinha, Siddharth and Zhao, Bojin and Bhaskaran, Shanmuga Priya and Huang, Teng and Wu, Xiaobing and Chian, Jia Sheng and Guo, Maoni and Kou, Si Hoi and Lei, Huijun and Zhang, Li and Wang, Xiaoyu and Lagniton, Philip Naderev P and Xiao, Fengxia and Jiang, Xinyang and Wang, San Ming},
title = {Ethnic‐specificity, evolution origin and deleteriousness of Asian BRCA variation revealed by over 7500 BRCA variants derived from Asian population},
journal = {International Journal of Cancer},
year = {2023},
volume = {152},
number = {6},
pages = {1159--1173},
doi = {10.1002/ijc.34359}
}
EUVIMED